Discoveries in Health Policy

Ideas for or from an evolving healthcare system

Thursday, November 19, 2026

USPSTF - It's Baaaack! Agenda Nov 19-20, 2026

›
Famously, meetings of USPSTF ceased shortly after the 2025 inauguration, and many members of the task force termed-out or were released from...
Wednesday, November 18, 2026

Will Analogies Speed You Through Regulators? Through Coverage?

›
Using health technology as an example, a new article in Harvard Business Review gives data-based tips on how to succeed with regulators - an...

AMA CPT for February 4-6, Lab Codes Posted for Early Comment

›
 AMA CPT hasn't yet posted registration for the February 2027 Los Angeles AMA CPT. https://www.ama-assn.org/membership/events/cpt-editor...

Trop2 as Oncology Companion Diagnostic: Pivotal Paper from Garassino et al.

›
 We've been hearing for a couple years that important new antibody-payload drugs will need IHC diagnostics, rather than the genomic ones...

AMA November 20: Town Hall on Defining "Widespread Use"

›
 One of the trickiest gates between you and a new AMA CPT code is "widespread use."  AMA deliberately doesn't define it, becau...
Tuesday, November 17, 2026

Geneoscopy, Exact Sciences: All Patent Claims Settled ("Obviousness")

›
On November 17, 2026, a press release from Geneoscopy announces the settlement of claims and counterclaims between the two companies. Pivot...
Monday, November 16, 2026

CMS RELEASES "CRUSH" ANTI FRAUD RULE: ZIPPO RE LABS

›
CMS has released a proposed version of its new anti fraud CRUSH rules.  While the roll-out seemed to be "half DME and half lab industry...

CMS Publishes Template for Uses of SUPER INTELLIGENCE in Medicare, Medicaid

›
Recall that recently, HHS ordered that HHS, CMS, NIH, FDA, all use "SUPER INTELLIGENCE" rather than artificial intelligence.  My b...

FDA Downclassifies Again: IHC for CDx

›
Update: See also Kelly Gordon's Linked In article here . # # # I posted a blog on September 3, 2026, that FDA had recently downclassifi...

Using AI at my Desk at Work: A Weekly Agentic Search for AI Report Generation Advances (Radiology or Pathology)

›
Each Monday, I used "agentic AI" to run a complex scheduled AI search in Chat GPT.  The topic is new publications related to gener...
Thursday, November 12, 2026

Two Authors, Two Books on Digital Pathology

›
 This week, I ran across two authors on Linked In who have each written a book that introduces the world of digital pathology. The first aut...

Brief Blog: How CMS Updates Products Covered Under NCDs

›
A brief update on how CMS covers products that are covered by definition, under an NCD.   The example here is NCD 90.2, Uses of NGS in Cance...
Wednesday, November 11, 2026

PAMA: The Secret Data Views that CMS Never Displays (for GSP Genomic Sequencing Procedures)

›
Medicare genomic sequencing pricing under PAMA is based on anywhere from 200 to 275,000 claims for the "GSP" service type.   For E...
Tuesday, November 10, 2026

Devil in the Details; Understanding GeneDx's Earning Shocks via Reimbursement

›
  GeneDx Earnings Calls Show Why Reimbursement Determines the Economics of Genomic Testing GeneDx’s May earnings shock (down 50%) exposed t...
Sunday, November 8, 2026

Chris Klomp: #2 at HHS, Update on his Views and Priorities for CMS

›
HEADER.  Chris Klomp is about to become the official #2 at HHS - the Deputy Secretary.  How does Klomp think Medicare should pay for innova...
›
Home
View web version

About the Author

My photo
Bruce
Bruce Quinn MD PhD is an expert on health reform, innovation, and Medicare policy. He helps both large and small companies understand and overcome hurdles to commercialization, as well as craft business strategies for a changing environment. CONTACT Dr. Quinn through www.brucequinn.com. BACKGROUND: Dr. Quinn has worked in academic medicine, Accenture business strategies, and for the Medicare program. EDUCATION: Stanford MD/PhD, MIT Postdoc, Kellogg MBA.
View my complete profile
Powered by Blogger.